Browsing by Author Marshall, Amy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2012Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesisMarshall, Amy; Grosveld, Gerard; Central Clinical School: Centenary InstituteAlveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis, Skeletal Muscle, vol.2, 1, 2012,pp 1-14
2017ASCT2 regulates glutamine uptake and cell growth in endometrial carcinomaAnderson, Lyndal; Holst, Jeffrey; Marshall, Amy; Nagarajah, Rajini; Otte, N; Pang, Angel; Rasko, John; Thoeng, Annora; van Geldermalsen, Michelle; Vellozzi, Melissa; Wang, Kevin Qian; Zhang, Blake; Lum, Trina; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; School of Medical Sciences: Brain and Mind Centre; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; School of Medical Sciences: Physiology; Central Clinical School: Centenary Institute; Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary InstituteASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma, Oncogenesis, vol.6, N/A, 2017,pp 1-10
2013The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cellsBailey, Charles; Feng, Yue; Holst, Jeffrey; Marshall, Amy; Metierre, Cynthia; Rasko, John; Tiffen, Jessamy; Wang, Qian; Watson, Sarah L.; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary InstituteThe cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells, International Journal of Cancer, vol.133, 7, 2013,pp 1603-1613
2014CTCF and BORIS in genome regulation and cancerBailey, Charles; Marshall, Amy; Rasko, John; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary InstituteCTCF and BORIS in genome regulation and cancer, Current Opinion in Genetics & Development, vol.24, N/A, 2014,pp 8-15
2017CTCF genetic alterations in endometrial carcinoma are pro-tumorigenicAnderson, Lyndal; Bailey, Charles; Biro, Mate; Champ, K; Feng, Yue; Marshall, Amy; Metierre, Cynthia; O'Young, Patrick; Rasko, John; Schmitz, Ulf; Thoeng, Annora; Vellozzi, Melissa; Ding, L; Jayasinghe, R; Mardis, Elaine; Richards, Anthony; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; School of Medical Sciences: Physiology; MedicineCTCF genetic alterations in endometrial carcinoma are pro-tumorigenic, Oncogene, vol.36, 29, 2017,pp 4100-4110
2016LAT1 is a putative therapeutic target in endometrioid endometrial carcinomaAnderson, Lyndal; Holst, Jeffrey; Marshall, Amy; Otte, Nicholas; Rasko, John; Thoeng, Annora; van Geldermalsen, Michelle; Vellozzi, Melissa; Wang, Kevin Qian; Zhang, Blake; Lum, M; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; School of Medical Sciences: Physiology; Central Clinical School: Centenary Institute; Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary InstituteLAT1 is a putative therapeutic target in endometrioid endometrial carcinoma, International Journal of Cancer, vol.139, 11, 2016,pp 2529-2539
2016LAT1 is a putative therapeutic target in endometrioid endometrial carcinomaAnderson, Lyndal; Holst, Jeffrey; Marshall, Amy; Otte, Nicholas; Rasko, John; Thoeng, Annora; van Geldermalsen, Michelle; Vellozzi, Melissa; Wang, Kevin Qian; Zhang, Blake; Lum, M; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; School of Medical Sciences: Physiology; Central Clinical School: Centenary Institute; Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary InstituteLAT1 is a putative therapeutic target in endometrioid endometrial carcinoma, International Journal of Cancer, vol.139, 11, 2016,pp 2529-2539
2013PAX3-FOXO1 induces up-regulation of Noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosisMarshall, Amy; Grosveld, Gerard; Klein Geltink, Ramon; Picchione, Fabrizio; Central Clinical School: Centenary InstitutePAX3-FOXO1 induces up-regulation of Noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosis, NeoPlasia: an international journal of oncology research, vol.15, 7, 2013,pp 738-748